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We examined the antiproliferation eﬀect of Jaceosidin (4 ,5 ,7 - t r i h y d r o x y - 3  , 6-dimethoxyﬂavone) isolated from the herb of
Artemisia vestita Wall on several human cancer cell lines. Jaceosidin signiﬁcantly reduced the proliferation of CAOV-3, SKOV-
3, HeLa, and PC3 cells in a concentration-dependent manner. A time-dependent inhibition was also observed in CAOV-3 cells by
Jaceosidin. By ﬂow cytometric analysis, we found that Jaceosidin treatment resulted in an increased apoptosis in CAOV-3 cells.
The cells treated with Jaceosidin exhibited a decreased mitochondrial membrane potential. Jaceosidin also increased the level of
cleaved caspase-9 and induced the cleavage of caspase-3 and poly (ADP-ribose) polymerase (PARP), while caspase-3 inhibitor
Z-DEVD-FMK signiﬁcantly reversed the proapoptotic eﬀect of Jaceosidin in CAOV-3 cells. Moreover, Jaceosidin elevated the level
of cytochrome c in cytosol. These ﬁndings suggest that the anticancer eﬀect of Jaceosidin may be contributed by an induction of
apoptosis involving cytochrome c release from mitochondria to cytosol.
Copyright © 2008 Wen Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The normal cell function and tissue homeostasis are main-
tained by a balance between proliferation and apoptosis.
Cancerisatypicaldisorderinwhichclonesofmalignantcells
escape such balance and proliferate inappropriately without
compensatory apoptosis [1]. Generally, the growth rate of
preneoplasticormalignantcellsoutpacesthatofnormalcells
as a consequence of malfunctioning or deregulation of their
cell growth and cell death machineries [2]. The success of
cancer therapies, therefore, greatly relies on the extent to
which they preferentially induce tumour cell death while
allowing survival of normal tissue. Blockade of proliferation
or induction of apoptosis has been recognized as a rational
approach to eliminate genetically damaged or preneoplastic
cells before any malignancy manifests [3–6].
As an important resource of anticancer agents, many
plant-derived substances have been shown to have various
bioactivities. For example, some of the Artemisia plants
widely used in traditional oriental medicine have been
reported to show antimutagenic and anti-inﬂammatory
eﬀects [7–9]. Our previous study has also observed that
the ethanol extract from Artemisia vestita Wall showed
an inhibitory eﬀect on endotoxin-induced sepsis through
suppressing MAPKs and NF-κB signaling in macrophages
[10]. From the plant, we further found an anticancer
principle, a ﬂavone jaceosidin. So far, there are only a
few reports on the pharmacological activities of this com-
pound, such as inhibition of COX-2 and MMP-9 in human
mammary epithelial cells [11], suppression of E6 and E7
oncoproteins of HPV 16 [12], and induction of apoptosis
in ras-transformed human breast epithelial cells [13]. Based
on the antiproliferation and apoptosis-inducing eﬀects of
jaceosidin, thus, the present study aims at demonstrating the
mechanisms underlying the eﬀects against cancer cells from
the aspect of apoptosis pathway.
2. MATERIALS AND METHODS
2.1. Celllines
Human ovary cancer cells CAOV-3, SKOV-3, PC3, and
HeLa cells were obtained from ATCC. All the cells were
maintained in DMEM (Life Technologies Inc., Grand Island,
NY, USA) supplemented with 10% FBS (Life Technologies
Inc.),100U/mLpenicillin,and100μg/mLstreptomycin,and2 Journal of Biomedicine and Biotechnology
incubated at 37◦C in a humidiﬁed atmosphere containing
5% CO2 in the air.
2.2. Drugsandreagents
Jaceosidin, 4 ,5 ,7 - t r i h y d r o x y - 3  , 6-dimethoxyﬂavone (see
Figure 1(a)), was isolated from Artemisia vestita Wall, a tra-
ditional Tibetan medicine. The following reagents were pur-
chased as follows. 3-(4, 5-dimethyl-2-thiazyl)-2, 5-diphenyl-
2H-tetrazolium bromide (MTT) (Sunshine Biotechnology,
Nanjing, China); antibodies to poly (ADP-ribose) poly-
merase (PARP), caspase-3, caspase-9, cytochrome c oxidase
subunit IV (COX-IV), and cytochrome c (Cell signaling
Technology,Beverly,Mass,USA);antibodytotubulin(Stanta
Cruz Biotechnology, Stanta Cruz, Calif, USA); peroxidase-
labeled antirabbit antibody, peroxidase-labeled antimouse
antibody (KPL, Gaithersburg, Md, USA); 5, 5 ,6 ,6  -
tetrachloro-1, 1 ,3 ,3  -tetraethyl-benzimidazolcarbocyanine
iodide (JC-1) (Molecular Probes, Eugene, Ore, USA). Z-
DEVD-FMK (BD biosciences, San Jose, Calif, USA).
2.3. MTTassay
Five thousands of cells per well were cultured in a 96-
well-plate for ﬁrst 24 hours. Then, they were incubated
with diﬀerent concentrations of jaceosidin (10, 20, 40, and
80μM) for further 48 hours. For the time course assay, the
incubation time with jaceosidin was 24, 48, and 72 hours,
respectively. After incubation, MTT was dissolved in PBS at
5mg/mL and added to culture media at a ﬁnal concentration
of 0.5mg/mL. After incubation at 37◦C for 4 hours, the
media were removed, 100μLD M S Ow e r ea d d e dt oe a c h
well to dissolve purple crystals of formazan. The plate was
shaken for 10 minutes to allow complete solubilization.
Spectrophotometric absorbance at 540nm was read on a 96-
well plate reader.
2.4. Assayforcellapoptosis
Jaceosidin or quercetin was added into 12-well-plate at
indicated concentrations. In the inhibitory assay, 100μLZ -
DEVD-FMK, a capase-3 inhibitor, was added to each well
along with the compounds. Twenty four-hours later, the cells
were collected, washed, and resuspended in PBS. Apoptotic
cell death was identiﬁed by double supravital staining with
recombinant FITC (ﬂuorescein isothiocyanate)-conjugated
Annexin V and PI, using the Annexin V-FITC Apoptosis
Detection kit (Becton Dickinson, Frankly Lakes, NJ, USA)
according to the manufacturer’s instructions. Flow cyto-
metric analysis was performed immediately after supravital
staining. Data acquisition and analysis were performed in
a Becton Dickinson FACSCalibur ﬂow cytometer using
CellQuest software.
2.5. Assayforcellmitochondrialmembranepotential
The JC-1 dye assay was used for determination of reduction
in mitochondrial membrane potential during apoptosis.
Brieﬂy, jaceosidin or quercetin was added to 12-well-plate
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Figure 1: (a) Structure of jaceosidin. (b) Jaceosidin inhibits
proliferation of CAOV-3, SKOV-3, PC3, and HeLa cells in a
concentration-dependent manner. Cells were cultured in 96-well-
plate for ﬁrst 24 hours. Then, they were treated with diﬀerent
concentrations of jaceosidin for further 48 hours. (c) Jaceosidin
inhibits proliferation in CAOV-3 cells in a time-dependent manner.
The CAOV-3 cells were incubated with jaceosidin for 24, 48,
and 72 hours, respectively. MTT assay was used to evaluate the
proliferation rate. Each datum indicated mean ± s.d. of three
independent experiments. ∗P<. 05, ∗∗P<. 01 versus control
(Dunnett’s test).Wen Lv et al. 3
at indicated concentration. Twenty-four hours later, cells
were harvested and ﬁxed in 0.5% PFA for 30 minutes. Then,
cells were stained with 1μLJ C - 1a t1 m g / m Li nD M S O .
After incubation with JC-1 for 15 minutes at 37◦C, cells
were analyzed for the decrease in red-orange ﬂuorescence.
Data acquisition and analysis were performed in a Becton
Dickinson FACSCalibur ﬂow cytometer using CellQuest
software.
2.6. Gelelectrophoresisandwesternblotanalysis
Cells were incubated for 24 hours in the presence of
indicated concentrations of jaceosidin or quercetin. After the
incubation,thecellswereharvestedandlysed.Mitochondrial
protein and cytosolic protein were isolated using Mitochon-
drial Fractionation Kit (Active Motif, Carlsbad, Calif, USA)
according to the manufacturer’s instructions. Proteins were
quantiﬁed using a BCA protein assay kit (Pierce, Rockford,
Ill, USA) according to the manufacturer’s speciﬁcations. For
western blot analysis, the proteins were electrophoresed on
a 7.5 to 10% SDS-PAGE, followed by immunoblotting on
PVDF membrane. Then, the membrane was blocked with
5% nonfat dry milk in TBS with 0.1% Tween 20 for 1 hour
at room temperature. Finally, proteins were visualized using
the enhanced chemiluminescence detection system (Cell
Signaling Technology, Beverly, Mass, USA) after incubation
with antibodies to PARP, caspase-3, caspase-9, cytochrome
c, COX-IV, or tubulin overnight at 4◦C. Then, they were
incubated with peroxidase-labeled antirabbit antibody or
peroxidase-labeled antimouse antibody for 1 hour at room
temperature.Peroxidase activity wasvisualized on X-ray ﬁlm
in darkroom.
2.7. Statisticalanalysis
Results were expressed as mean ± s.d. of three independent
experiments and each experiment included triplicate sets.
Data were statistically evaluated by one-way ANOVA fol-
lowed by Dunnett’s test between control group and multiple
dose groups, with the level of signiﬁcance chosen as P<. 05.
3. RESULTS
Jaceosidinconcentration-dependentlyand
time-dependentlyinhibitedproliferationof
variouscancercells
To examine the eﬀects of jaceosidin on diﬀerent kinds of
tumour cells, exponentially growing cells were treated by
jaceosidin for 48 hours. As shown in Figure 1(b), jaceosidin
signiﬁcantly reduced the proliferation of CAOV-3, SKOV-
3, PC3, and HeLa cells in a dose-dependent manner. The
ﬂavone also showed a time-dependent inhibition on the
proliferation of CAOV-3 cells (see Figure 1(c)).
JaceosidininducedapoptosisinCAOV-3cellsin
acaspase-3-dependentmanner
As shown in Figures 2(a) and 2(b), Annexin-V positive cells
were considered as early and late apoptosis populations.
Treatment of jaceosidin induced apoptosis of CAOV-3
cells in a dose-dependent manner. Against the apoptosis
induction, caspase-3 inhibitor Z-DEVD-FMK signiﬁcantly
reversedtheproapoptoticeﬀectofjaceosidininCAOV-3cells
(see Figure 2(c)).
Jaceosidininducedlossofmitochondrialmembrane
potential(MMP)andcytochromecreleasefrom
mitochondriatocytosol
In Figure 3(a), mitochondrial potential alteration was exam-
ined upon jaceosidin treatment. CAOV-3 cells were incu-
bated with jaceosidin or quercetin for 24 hours. As the
result, a dose-dependent reduction in MMP was detected in
the groups treated with jaceosidin. Quercetin also showed a
strong decrease in MMP.
To conﬁrm if jaceosidin induces apoptosis through
mitochondrial pathway, we incubated CAOV-3 cells with
jaceosidin for 24 hours. Then, we collected cells and
isolated mitochondria protein. Thirty μgo fe a c hp r o t e i n
were subjected to Western blotting. Equal protein load-
ing was conﬁrmed by immunodetection of COX-IV for
mitochondria protein or tubulin for cytosol protein. As
showninFigure 3(b),jaceosidin greatlyincreasedthecytosol
cytochrome c and decreased the mitochondria cytochrome c
as compared with the control group.
Jaceosidinactivatedcaspase-3anditsrelatedproteinsto
promoteapoptosis
Toexaminethestatusofthecaspase-3protein,weperformed
Western blot analysis by using an anticaspase-3 antibody,
which recognizes both procaspase-3 and cleaved caspase-
3, the p17 large/active subunit of caspase-3. As shown in
Figure 4, the p17 cleavage product appeared in lysates of
CAOV-3 cells treated with 80μM jaceosidin and 10μM
quercetin. Jaceosidin and quercetin also cleaved PARP to a
band of 85kDa. The amount of cleaved caspase-9 was also
increased signiﬁcantly in the cells treated with quercetin, and
slightly with jaceosidin.
4. DISCUSSION
Inthepresentstudy,weﬁrstexaminedtheeﬀectofjaceosidin
on some kinds of cancer cell lines (see Figure 1(b)). CAOV-3
cells were initiated from human ovary adenocarcinoma of a
54-years-old Caucasian female [14]. SKOV-3 is also a human
ovary adenocarcinoma cell line, and it is resistant to tumor
necrosis factor and to several cytotoxic drugs including
diphtheria toxin, cis-platinum and adriamycin [15]. PC3, as
an epithelial cell line, was established from a human grade
IV prostatic adenocarcinoma metastatic to bone [16]. And
HeLa cells are human cervix adenocarcinoma cells [17].
Though the inhibition of proliferation rate by jaceosidin
was observed to diﬀerent degrees against diﬀerent kinds of
cancer cells, a concentration-dependent action was shown
in all 4 kinds of cell lines used. This ﬁnding suggests that
jaceosidin may have a relatively wide spectrum of antitumor
growth. In CAOV-3 cells, the compound also showed a4 Journal of Biomedicine and Biotechnology
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Figure 2: Jaceosidin promotes apoptosis of CAOV-3 cells in a caspase-3-dependent manner. CAOV-3 cells were seeded in 12-well-plate
overnight, and then were treated with diﬀerent concentrations of jaceosidin or 10μM quercetin in the presence or absence of 100μMZ -
DEVD-FMK for 24 hours. Annexin-V/PI stain was used to measure apoptosis rate. Apoptosis rate is measured by ﬂow cytometry. (a)
The results are representative of three separate experiments. (b) Data are expressed as a histogram of mean ± s.d. of three independent
experiments. (c) Eﬀect of Z-DEVD-FMK on the proapoptotic activity of jaceosidin. Each datum indicated mean ± s.d. of three independent
experiments. ∗P<. 05, ∗∗P<. 01 (Dunnett’s test).
time-dependent inhibition against the cell proliferation (see
Figure 1(c)). As the ovary cancer cell line CAOV-3 showed
the most signiﬁcant inhibitory rate, we chose it to do the
following studies.
Apoptosis, a morphologically and biochemically deﬁned
form of cell death [18], plays a role in a wide variety of
biologic systems. As apoptosis is often caused by chemother-
apeutic drugs [19], we used annexin V-PI staining to study
the apoptosis rate of cells treated with jaceosidin (see Figures
2(a) and 2(b)). The result indicated that jaceosidin could
dose-dependently induce the apoptosis of CAOV-3 cells. The
IC50 was less than 40μM. Treatment of caspase-3 inhibitor
led to a blockade of the proapoptotic eﬀect of jaceosidin
(see Figure 2(c)), indicating caspase-3 is involved in the
underlying mechanism of jaceosidin’s anticancer eﬀect.
Chemotherapeutic agents have been described to induce
apoptosis in two major routes: the extrinsic or death
receptor-associated route and the intrinsic or mitochondrial
route [20]. In the intrinsic route the execution phase is
initiated by release of cytochrome c and other polypeptides
from the mitochondrial intermembrane space [21]. This
release is accompanied by a dissipation of mitochondrial
inner transmembrane potential [22]. It was reported that
quercetin, another widely used ﬂavone, has strong proapop-
toticeﬀectincancercells[23].Inthepresentstudy,weusedit
as positive control in the apoptosis assay for comparison. To
further access the antitumour mechanism of jaceosidin, we
observed that mitochondrial membrane potential decreased
in a dose-dependent manner by jaceosidin (see Figure 3(a)).
This result suggests that jaceosidin probably promotes theWen Lv et al. 5
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Figure 3: Jaceosidin dose-dependently (a) induces loss of mito-
chondrial membrane potential and (b) induces cytochrome c to
release from mitochondria to cytosol. CAOV-3 cells were seeded
into 12-well-plate and cultured overnight. Jaceosidin or quercetin
was added into each well. Twenty-four hours later, cells were
harvested for measuring mitochondrial membrane potential by
ﬂow cytometry using JC-1 staining. Cells on the lower side showed
lower membrane potential. One of three independent experiments
is shown. In addition, mitochondria and cytosol proteins were
prepared from cells treated with 80μM jaceosidin, which were
subjected to western blotting for measuring cytochrome c in
mitochondria and cytosol.
mitochondrial pathway. As expected, the next experiment
further demonstrated that jaceosidin treatment greatly
induced the cytochrome c to release from mitochondria to
cytosol in the cells (see Figure 3(b)), indicating involvement
of the intrinsic apoptosis route via mitochondria.
Once released into the cytoplasm, cytochrome c usually
interacts with Apaf-1 (apoptotic protease-activating factor-
1), adenosine triphosphate-deoxyadenosine triphosphate
(ATP/dATP), and procaspase-9 to form a complex known
as the apoptosome [24]. In the apoptosome, caspase-9
is activated which in turn activates eﬀector caspases, like
procaspase-3 and -7 [25]. The eﬀector caspases may cleave
Control
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40 80
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Cleaved
caspase-9
Caspase-3
Tubulin
116kD
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Figure 4: Jaceosidin activates caspase-3 and its related proteins
to promote apoptosis. Whole cell lysates prepared from CAOV-3
cells, which had been incubated with jaceosidin or quercetin for 24
hours. The proteins were subjected to Western blot analysis using
the respective antibodies as indicated. Data are representative of
three separate experiments.
a number of structural and regulatory cellular proteins
including PARP and lamin protein and are responsible
for the typical morphologic and biochemical features of
an apoptotic cell [26, 27]. Figure 4 showed the eﬀects
of jaceosidin on these events occurred in the apoptosis,
where jaceosidin markedly caused increases in the cleaved
form of PARP, caspase-3, and caspase-9. This result fur-
ther conﬁrmed that jaceosidin promotes apoptosis through
capase-3 via mitochondria. Walle et al. reported that 5, 7-
dimethoxyﬂavone and 5, 7, 4 -trimethoxyﬂavone were both
10 times more potent inhibitors of cell proliferation than the
corresponding unmethylated analogs chrysin and apigenin,
fully methylated ﬂavones appear to have great potential
as cancer chemopreventive/chemotherapeutic agents [28].
However, in our experiments, quercetin (3, 3 ,4  ,5 ,
7-pentahydroxyﬂavone) showed obviously better eﬃcacy
than jaceosidin (4 , 5, 7-trihydroxy-3 , 6-dimethoxyﬂavone).
Comparison of the structure of these compounds suggested
that 3-hydroxyl group might be very important for the
function of ﬂavone compounds. Further experiments need
to be done to conﬁrm this hypothesis.
Overall, our study has proved an antitumour eﬀect of
jaceosidin, a ﬂavone from Artemisia vestita Wall. Its mech-
anism underlying the eﬀect mainly involves the induction
of apoptosis through activating caspase-3 via mitochondrial
pathway. The ﬁndings obtained here may be helpful for
understanding the properties of jaceosidin as a candidate of
antitumour drug.
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